GlassScriptPhysician profile
Crystal D Hudson
NPI 1558723270
$1,375.32
in general payments reported to CMS, 2019-2025
20 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,081 · 2022: $96.51 · 2023: $41.14 · 2024: $20.82 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $197.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $323.10 | 2021 | |
| Abbvie INC. | $248.59 | 2021 | |
| Boston Scientific Corporation | $199.04 | 2021-2022 | |
| Gilead Sciences, INC. | $102.52 | 2021 | |
| Nevro Corp. | $86.59 | 2022-2024 | Senza |
| Globus Medical, INC. | $85.05 | 2025 | Senza |
| Medtronic, INC. | $41.89 | 2021 | |
| Merck Sharp & Dohme LLC | $39.08 | 2021 | |
| Curonix LLC | $26.73 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Phadia US INC. | $24.38 | 2021 | |
| Nalu Medical, INC. | $24.18 | 2023 | Nalu Neurostimulation System |
| Janssen Biotech, INC. | $23.92 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $23.69 | 2025 | |
| Painteq LLC | $23.67 | 2022 | |
| Nestle Healthcare Nutrition INC. | $23.33 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $19.83 | 2021 | |
| Redhill Biopharma INC. | $17.92 | 2021 | |
| Daiichi Sankyo INC. | $16.03 | 2021 | |
| Qol Medical, LLC | $14.01 | 2021 | |
| Allergan, INC. | $11.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Hudson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.